# Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition

> **NCT01618825** · PHASE1 · COMPLETED · sponsor: **IPCA Laboratories Ltd.** · enrollment: 28 (actual)

## Conditions studied

- Fed

## Interventions

- **DRUG:** Lamotrigine Tablets 25 mg
- **DRUG:** Lamotrigine

## Key facts

- **NCT ID:** NCT01618825
- **Lead sponsor:** IPCA Laboratories Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2012-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01618825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01618825, "Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01618825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*